- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06111677
SOFA and APACHE II Scoring Systems for Predicting Outcome of Neurological Patients Admitted in a Tertiary Hospital Intensive Care Unit
October 31, 2023 updated by: Sumit Shahi, Tribhuvan University Teaching Hospital, Institute Of Medicine.
The aim of this study was to compare the discriminative power of commonly used scoring systems, namely the sequential organ failure assessment (SOFA) and acute physiology and chronic health evaluation II (APACHE II) in the intensive care unit of a tertiary care hospital.
Study Overview
Status
Completed
Conditions
Detailed Description
This was a retrospective cross-sectional study including patients admitted to the ICU of TU Teaching Hospital with a neurological diagnosis from January 1, 2022, to December 31, 2022.
This study uses data collected prospectively as part of the Nepal Intensive Care Research Foundation (NICRF) dataset.
The ICU database contained information for all components of the APACHE II and SOFA score with physiological data collected for the length of ICU, and hospital stay.
Both SOFA and APACHE II were calculated from the admission data or if not available from the earliest data recorded after admission in ICUs.
Study Type
Observational
Enrollment (Actual)
153
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Lalitpur, Nepal, 09771
- Sumit Shahi
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
All the patients admitted in ICUs with neurological diagnosis from January 1, 2022 to December 31, 2022
Description
Inclusion Criteria:
- Patients admitted with neurological diagnosis in ICUs
Exclusion Criteria:
- Patients with missing data
- Patients with ICU length of stay < 24 h
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mortality
Time Frame: 1 year
|
The outcome measure was ICU mortality (survivor vs non-survivor)
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 15, 2023
Primary Completion (Actual)
August 1, 2023
Study Completion (Actual)
September 1, 2023
Study Registration Dates
First Submitted
October 24, 2023
First Submitted That Met QC Criteria
October 31, 2023
First Posted (Actual)
November 1, 2023
Study Record Updates
Last Update Posted (Actual)
November 1, 2023
Last Update Submitted That Met QC Criteria
October 31, 2023
Last Verified
October 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NeurologicalOutcomeICU
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Individual particant data was taken from ICU database with deidentified data after taking permission
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neurologic Disorder
-
Abant Izzet Baysal UniversityNot yet recruiting
-
Fondation Ellen PoidatzRecruiting
-
Chung-Ang University Gwangmyeong HospitalNot yet recruitingNeurologic Disorder
-
Medical University of ViennaNeurologisches Rehabiliationszentrum RosenhügelRecruitingNeurologic DisorderAustria
-
Rehabilitation Hospital of Overland ParkDiscovery StatisticsRecruitingNeurologic DisorderUnited States
-
Wake Forest University Health SciencesIndiana University; Norton Healthcare; Child Neurology FoundationCompletedNeurologic DisorderUnited States
-
University Hospital, ToulouseIpsenCompleted
-
NHS LothianCompleted
-
Henri Mondor University HospitalNot yet recruiting
-
Pôle Saint HélierINSA RennesCompleted